Trader consensus on Polymarket reflects a 66.5% implied probability that the CDC will issue a Level 3 Travel Health Notice—advising travelers to reconsider nonessential travel due to an outbreak—for any disease by December 31, 2026, spurred by the agency's May 8 activation of its Emergency Operations Center at Level 3 (routine heightened readiness) for a hantavirus cluster tied to the MV Hondius cruise ship, involving seven cases across multiple countries including three fatalities. Distinct from Travel Health Notices, this rodent-borne incident highlights surveillance gaps, with no U.S. cases reported and overall domestic risk rated extremely low by CDC. No Level 3 notices are active, only recent Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte (March 10), alongside ongoing H5N1 avian influenza monitoring showing no person-to-person transmission per FluView Week 17. With seven months remaining, traders weigh potential escalations from vector-borne or respiratory pathogens against historical rarity of Level 3 designations; watch weekly CDC surveillance reports and WHO updates for shifts.